1. Home
  2. RBC vs VTRS Comparison

RBC vs VTRS Comparison

Compare RBC & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RBC Bearings Incorporated

RBC

RBC Bearings Incorporated

HOLD

Current Price

$586.24

Market Cap

18.5B

Sector

Industrials

ML Signal

HOLD

Logo Viatris Inc.

VTRS

Viatris Inc.

HOLD

Current Price

$13.89

Market Cap

17.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RBC
VTRS
Founded
1919
1961
Country
United States
United States
Employees
5334
30000
Industry
Metal Fabrications
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.5B
17.2B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
RBC
VTRS
Price
$586.24
$13.89
Analyst Decision
Buy
Buy
Analyst Count
6
4
Target Price
$510.00
$13.50
AVG Volume (30 Days)
150.9K
7.2M
Earning Date
05-15-2026
05-07-2026
Dividend Yield
N/A
3.45%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$14,299,900,000.00
Revenue This Year
$14.77
$4.41
Revenue Next Year
$12.09
$1.96
P/E Ratio
$64.90
N/A
Revenue Growth
N/A
N/A
52 Week Low
$310.95
$7.39
52 Week High
$603.67
$16.47

Technical Indicators

Market Signals
Indicator
RBC
VTRS
Relative Strength Index (RSI) 61.09 54.55
Support Level $368.23 $12.90
Resistance Level $589.17 $16.38
Average True Range (ATR) 14.65 0.31
MACD 4.91 0.11
Stochastic Oscillator 80.85 97.33

Price Performance

Historical Comparison
RBC
VTRS

About RBC RBC Bearings Incorporated

RBC Bearings Inc is an international manufacturer and marketer of engineered precision bearings, components, and essential systems for the industrial, defense, and aerospace industries. The offering includes plain bearings, roller bearings, ball bearings, and engineered products. The company has two reportable segments: Industrial, which derives maximum revenue, and Aerospace/Defense. The Aerospace/Defense segment represents the end markets for the company's engineered bearings and precision components used in commercial aerospace, defense aerospace, and sea and ground defense applications; and the Industrial segment represents the end markets for its products used in various industrial applications. Geographically, the company generates a majority of its revenue from the United States.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: